Velan Capital Investment Management LP - ELEVATION ONCOLOGY INC ownership

Quarter-by-quarter ownership
Velan Capital Investment Management LP ownership history of ELEVATION ONCOLOGY INC
ValueSharesWeighting
Q3 2023$329,510
-56.4%
497,2990.0%0.27%
-62.1%
Q2 2023$755,894497,2990.70%
Other shareholders
ELEVATION ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 2,834,910$22,084,0004.40%
venBio Partners LLC 2,608,167$20,318,0002.02%
Samsara BioCapital, LLC 932,240$7,262,0001.14%
Cormorant Asset Management, LP 1,983,165$15,140,0000.62%
BVF INC/IL 1,590,298$12,388,0000.48%
Boxer Capital, LLC 1,341,530$10,451,0000.36%
CAXTON CORP 48,183$375,0000.30%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,997,564$15,561,0000.18%
Vivo Capital, LLC 496,843$3,870,0000.17%
CAAS CAPITAL MANAGEMENT LP 60,000$467,0000.01%
View complete list of ELEVATION ONCOLOGY INC shareholders